tm logo
TAKEDA
Live/Registered
REGISTERED

on 17 Dec 2024

Last Applicant/ Owned by

1-1, Doshomachi 4-chome, Chuo-ku

Osaka

JP

541-0045

Serial Number

98377551 filed on 26th Jan 2024

Registration Number

7608206 registered on 17th Dec 2024

in the Principal Register

Correspondent Address

Karl M. Zielaznicki, Esq.

Karl M. Zielaznicki, Esq. Troutman Pepper Hamilton Sanders LLP

c/o IP Services NYC

New York, NY 10022

United States

Filing Basis

1. filed as use application

2. use application currently

Disclaimer

NO DATA

TAKEDA

Medical devices used for administering pharmaceutical preparations for use in treating or diagnosing, disorders, diseases, and rare diseases in the field of autoimmunology, bacterial infection diseases and disorders, cardiology, central and peripheral nervous systems diseases and disorders, diabetes, endocrinology, hematology, hormonal diseases and disorders, gastroenterology, gout, immunology, in Read More

Classification Information


Class [010]
Medical Instrument Products


Medical devices used for administering pharmaceutical preparations for use in treating or diagnosing, disorders, diseases, and rare diseases in the field of autoimmunology, bacterial infection diseases and disorders, cardiology, central and peripheral nervous systems diseases and disorders, diabetes, endocrinology, hematology, hormonal diseases and disorders, gastroenterology, gout, immunology, infectious diseases and disorders, inflammatory diseases and disorders, musculoskeletal diseases and disorders, neuroscience, oncology, pain management, respiratory diseases and disorders, genetic diseases and disorders, urological diseases and disorders, kidney diseases and disorders, viral diseases and disorders; medical devices for reconstituting pharmaceutical preparations for use in treating or diagnosing disorders, diseases, and rare diseases in the field of autoimmunology, bacterial infection diseases and disorders, cardiology, central and peripheral nervous systems diseases and disorders, diabetes, endocrinology, hematology, hormonal diseases and disorders, gastroenterology, gout, immunology, infectious diseases and disorders, inflammatory diseases and disorders, musculoskeletal diseases and disorders, neuroscience, oncology, pain management, respiratory diseases and disorders, genetic diseases and disorders, urological diseases and disorders, kidney diseases and disorders, viral diseases and disorders; medical devices for reconstituting and administering pharmaceutical preparations. for use in treating or diagnosing, disorders, diseases, and rare diseases in the field of autoimmunology, bacterial infection diseases and disorders, cardiology, central and peripheral nervous systems diseases and disorders, diabetes, endocrinology, hematology, hormonal diseases and disorders, gastroenterology, gout, immunology, infectious diseases and disorders, inflammatory diseases and disorders, musculoskeletal diseases and disorders, neuroscience, oncology, pain management, respiratory diseases and disorders, genetic diseases and disorders, urological diseases and disorders, kidney diseases and disorders, viral diseases and disorders


First Use Date in General

01st Jan 2020

First Use Date in Commerce

01st Jan 2020

Mark Details


Serial Number

No 98377551

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 255541000475

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

26.17.01 -

Straight line(s), band(s) or bar(s)

26.17.05 -

Horizontal line(s), band(s) or bar(s)

26.17.09 -

Curved line(s), band(s) or bar(s)

Legal History


Show more

Status DateAction Taken
17th Dec 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
17th Dec 2024REGISTERED-PRINCIPAL REGISTER
15th Oct 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
15th Oct 2024PUBLISHED FOR OPPOSITION
25th Sep 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06th Sep 2024APPROVED FOR PUB - PRINCIPAL REGISTER
04th Sep 2024TEAS/EMAIL CORRESPONDENCE ENTERED
03rd Sep 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
03rd Sep 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
21st Aug 2024NON-FINAL ACTION E-MAILED